Isothermal Nucleic Acid Amplification Technology Market by Product (Assays, Kits, & Reagents, Systems), Type (Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification), Application, End-User - Glo

Isothermal Nucleic Acid Amplification Technology Market by Product (Assays, Kits, & Reagents, Systems), Type (Helicase-dependent Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence-based Amplification), Application, End-User - Global Forecast 2024-2030

The Isothermal Nucleic Acid Amplification Technology Market size was estimated at USD 3.77 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 13.64% to reach USD 9.22 billion by 2030.

The usage of isothermal nucleic acid amplification technology is increasing across hospitals and academic & research institutes, which enables the creation of DNA and RNA in the presence of a target molecule at constant temperatures. The isothermal amplification processes have greater efficiency, produce higher amplification yields, and need fewer sample preparation steps than polymerase chain reaction (PCR). This isothermal nucleic acid amplification technology is widely used as a molecular detection technique in blood screening and infectious disease diagnosis owing to its accuracy and ability to detect various molecules. Furthermore, the growing prevalence of antimicrobial and infectious diseases has increased the need to detect antimicrobial resistance genes and various pathogens, including bacteria and viruses. However, a lack of awareness and a stringent regulatory framework for isothermal nucleic acid amplification may limit their use in end-use sectors. The advancement in isothermal nucleic acid amplification techniques and approvals from healthcare regulatory authorities for innovative technologies are expected to create immense opportunities for the market.

Regional Insights

Americas represents a highly developing landscape for the isothermal nucleic acid amplification technology market characterized by an increasing number of diagnostic procedures across hospitals and academic & research institutes and an increasing introduction of innovative isothermal nucleic acid solutions. The development in healthcare infrastructure and increasing medical tourism in various Asia-Pacific regions, such as India, Thailand, Singapore, Malaysia, and South Korea, are expanding the need for isothermal nucleic acid amplification technology to detect viral diseases. In January 2023, Peking University reported that 900 million individuals had been infected with the coronavirus in China, and has further expected to expand the usage of isothermal nucleic acid amplification for the detection of SARS-CoV-2 RNA in research laboratories and diagnostic centers. Moreover, increasing the prevalence of infectious diseases and government initiatives for improving diagnostic procedures are subsequently expanding the use of isothermal nucleic acid amplification technology in the EMEA region. Additionally, rising approvals from healthcare regulatory authorities for innovative diagnostic technologies are expected to encourage the growth of isothermal nucleic acid amplification technology worldwide.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Isothermal Nucleic Acid Amplification Technology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Rising prevalence of antimicrobial and infectious diseases worldwide
Increasing adoption of INAAT for accurate & rapid testing results
Development of miniaturized nucleic acid-based diagnostics

Market Restraints

High cost of reagents and implementation of technology

Market Opportunities

Technological advancements in isothermal nucleic acid amplification
Increasing adoption of digital diagnostics and rising demand for point-of-care diagnostics solutions

Market Challenges

Limitation of isothermal nucleic acid amplification technology

Market Segmentation Analysis

Product: Advancements in isothermal nucleic acid amplification technology systems to scale up their operations and automate their workflows
Type: Growing preference for transcription-mediated amplification in clinical diagnostics for its rapid and high amplification capacity
Application: Extensive utilization of isothermal nucleic acid amplification technology for disease diagnoses for promoting better patient outcomes
End-User: Significant role of isothermal nucleic acid amplification technology in hospitals for rapid and accurate diagnostics to improve patient care

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Isothermal Nucleic Acid Amplification Technology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Isothermal Nucleic Acid Amplification Technology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Polish biotech Genomtec raises EUR 2.9 million (USD 3.19 million) from share issue

Genomtec, a Polish biotech startup, has recently raised EUR 2.9 million in a share issue funding round. The company focuses on Isothermal Nucleic Acid Amplification Technology, a molecular-level approach to diagnostics and testing with the potential to revolutionize healthcare. This new injection of funds enables Genomtec to continue its pioneering research into this exciting field, empowering healthcare professionals to deliver faster and more accurate diagnoses.

Stilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for Oncology

INAT, a novel isothermal nucleic acid amplification technology developed by Stilla Technologies and Atila Biosystems, has demonstrated its ability to accurately detect low amounts of target nucleic acid molecules in various biological samples. This groundbreaking technology promises faster and more reliable molecular diagnostics with minimal equipment requirements and shorter PCR testing time than traditional methods. INAT could revolutionize the molecular diagnostics market with its superior capabilities.

Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Sherlock Biosciences has recently made a significant move in molecular diagnostics by acquiring Sense Biodetection. By combining Sherlock’s isothermal nucleic acid amplification technology with Sense’s CRISPR-based detection platform, the company brings cost-effective, disposable diagnostic solutions to aid in the fight against worldwide health challenges. This acquisition demonstrates an impressive commitment to innovation and continued dedication to improving healthcare solutions for those needing it most.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Isothermal Nucleic Acid Amplification Technology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Isothermal Nucleic Acid Amplification Technology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AtilaBiosystems, Beijing SBS Genetech Co., Ltd., bioMérieux SA, Biosearch Technologies by LGC Limited, DiaSorin S.p.A., Eiken Chemical Co., Ltd., Fortis Life Sciences, LLC, GENOMTEC S.A., GenoSensor Corporation, Grifols S.A., highQu GmbH, Hologic, Inc., Illumina, Inc., Jena Bioscience GmbH, Life Sciences Advanced Technologies, Inc., Mast Group Ltd., Meridian Bioscience Inc. by SD Biosensor, Inc., New England Biolabs, Inc., OptiGene Limited, PCR Biosystems Ltd., QIAGEN GmbH, Quidel Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Ustar Biotechnologies (Hangzhou) Ltd, Xiamen Jiqing Biomedical Technology Co., Ltd., Zhengzhou Laboao Instrument Equipment CO., LTD, and Zhuhai Biori Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Isothermal Nucleic Acid Amplification Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Assays, Kits, & Reagents
Systems
Type
Helicase-dependent Amplification
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence-based Amplification
Strand Displacement Amplification
Transcription-mediated Amplification
Application
Blood Screening
Disease Diagnosis
CT/NG
Hepatitis
HIV
Influenza
End-User
Academic & Research Institutes
Hospitals
Reference Laboratories
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year